Hydrogen peroxide-mediated free radicals generation have been related with differential induction of peroxisomal b-oxidation and catalase by DHEA and other peroxisome proliferators, which are responsible for hydrogen peroxide formation and degradation, respectively, in the liver. Interestingly, several cellular detoxifying enzymes including glutathione transferase, glutathione peroxidase and superoxide dismutase were inhibited in the livers of DHEA-treated rats. 13, 14) As a result, there is an excess of un-metabolized hydrogen peroxide molecules that retain the capacity to cause oxidative DNA damage ultimately leading to neoplasm.
It was previously reported that DHEA depletes the endogenous mevalonic acid pool in human colon adenocarcinoma HT-29 cells. 15) Mevalonic acid serves as a precursor for biosynthesis of important isoprenoids in the mammalian cells. Ubiquinone, a mevalonate-derived isoprenoid, plays a critical role in cellular defense by virtue of its antioxidant properties. The aim of the present study was to determine whether mevalonic acid pool depletion following DHEA treatment, 15) resulted in decreased ubiquinone levels in the liver. The findings, however, indicate a temporal change of ubiquinone concentration in DHEA-treated rat hepatocytes along with catalase activity. ) and water ad libitum with a 12 h light/dark cycle and controlled temperature and humidity. After one week of acclimatization, the animals were randomly divided into 2 treatment groups: control or DHEA (300 mg/kg). DHEA suspended in 0.5% carboxymethyl cellulose was administered at 3 ml/kg, while the control animals received the vehicle. The animals were treated once daily by gastric intubation for 2 or 8 weeks where applicable. The duration of the experiment, dosage of DHEA and method of administration were based on previous literature reports. 12, 16) Twenty four hours after the last treatment, the animals were euthanized by CO 2 (100%). Immediately, prior to death, the livers of the rats were perfused in situ with chilled buffered saline (pH 7.4). 17) Liver homogenates were prepared in 20 mM Tris-HCl containing 0.25 M sucrose (pH 7.4) 17) and aliquots were frozen in amber-colored tubes at Ϫ70°C until further analyses were performed. Animal experiments were in accordance with the guidelines set by the Animal Care and Use Committee of East Carolina University.
MATERIALS AND METHODS

Chemicals
Spectrophotometric Assays Catalase activity of the liver was quantitated spectrophotometrically at 240 nm. 18) Lipid peroxidation was estimated using a colorimetric assay (Calbiochem Novabiochem, CA, U.S.A.). The values were corrected to protein concentration.
HPLC Determination of Hepatic Ubiquinone Content Total ubiquinone (oxidized and reduced forms) in rat liver homogenates was extracted according to the established methods 19, 20) using the ethanol-hexane solvent system and ubiquinone-6 as an internal standard. HPLC analysis was performed in a mobile phase containing 20 mM lithium perchlorate in ethanol-methanol mixture using an Ultrasphere ODS column (5 mm; 4.6 mmϫ2.5 cm; Beckman Instrument, Fullerton, CA, U.S.A.), 21) while the peaks were detected at 275 nm. Extraction recovery was corrected with the internal standard and values normalized to protein concentration.
Statistics Data are reported as meanϮS.E.M. (standard error of the mean). Student's t-test was used for statistical analysis using the statistical package GB STAT (version 5.0).
RESULTS AND DISCUSSION
In order to determine DHEA's effect on ubiquinone, two major isoforms of the isoprenoid namely ubiquinone-9 and -10 were quantitated in rat liver homogenate. Although DHEA did not produce any effect on ubiquinone-9 at 2 weeks, following 8 weeks of DHEA treatment, ubiquinone-9 concentration was increased 1.43 fold compared to control levels (Fig. 1) . The levels of ubiquinone-10 followed an opposite time course. There was a significant reduction of ubiquinone-10 at 2 weeks (pϽ0.05), while no difference was observed after 8 weeks (Fig. 2) . Figure 3 summarizes the results of catalase activity. Similar to previous observations, 12) we observed a marked increase in catalase activity in DHEA-treated rats (pϽ0.01) at 2 weeks with a return to a basal level at 8 weeks.
Lipid peroxidation serves as a marker of oxidative stress. As shown in Fig. 4 , there was a significant increase (pϽ0.01) in lipid peroxide after chronic exposure to DHEA, although no change was observed at 2 weeks time point. It is worthwhile to note that the basal levels of ubiquinone and catalase in the present study showed an age-related increase as reported previously by other investigators. 22, 23) Ubiquinone is an essential component of mitochondrial electron transport system. As an antioxidant, it quenches free radicals directly as well as through recycling of Vitamin E, another well-known chain-breaking antioxidant. 24) Ubiquinone-9, the predominant isoform of the coenzyme present in the rat liver contains nine isoprene moieties, whereas ubiquinone-10 is present at much reduced concentrations. 19) Data from the present study indicates a marked re- duction in hepatic ubiquinone-10 at 2 weeks in DHEAtreated rats. This finding supports the hypothesis of ubiquinone depletion, however, the effect was short lived. In contrast, ubiquinone-9, which remained at basal at 2 weeks was significantly elevated at 8 weeks following DHEA treatment. Thus, DHEA affects hepatic ubiquinone in an isomerspecific and time-dependent manner.
Interestingly, in a separate study from this laboratory, DHEA-sulfate (DHEAS), significantly increased ubiquinone-9 in the liver at 2 weeks, although no effect was observed with ubiquinone-10.
25) It is possible that the modulation of hepatic ubiquinone by DHEAS may be different from that of DHEA.
Catalase reduces cellular levels of hydrogen peroxide, thus serving as a protective mechanism against peroxide associated oxidative damage to cellular macromolecules.
As expected, catalase activity was significantly elevated by DHEA at 2 weeks. However, the return of catalase activity to control levels at 8 weeks, suggests the possible recruitment of alternative mechanisms in counteracting oxidative stress. In the present study, we observed a marked elevation of ubiquinone-9 in rat hepatocytes. Since other cellular defense enzymes, i.e. glutathione peroxidase, glutathione S-transferase and superoxide dismutase 13, 14) were inhibited by DHEA, the role of ubiquinone in peroxisome proliferation could be of potentially significant importance, especially after 8 week exposure to DHEA.
Ubiquinone-9 content in the rat liver elicited a pattern exactly opposite to catalase activity. This inverse relationship between catalase and ubiquinone-9 suggests that catalase provides a defense against acute oxidative stress, while ubiquinone-9 replaces catalase as a major antioxidant during chronic oxidative stress. Moreover, increased hepatic ubiquinone-9, resulting after prolonged DHEA treatment, possibly compensate for the inability of the cell to increase catalase activity to keep pace with elevated oxidative stress. This is the first report of an increase in ubiquinone-9 in DHEA-treated rodent liver. Unlike previous observations, 26) in the present study, the contribution of plasma ubiquinone was carefully eliminated by in situ perfusion of liver. Furthermore, a pharmacological dose of DHEA was used rather than incorporating the steroid in the diet which allows variations in dosage.
Increase of hepatic ubiquinone-9 after 8 weeks of DHEA treatment was in concert with a marked increase in lipid peroxidation. These findings provide evidence that the increase in ubiquinone-9 was a compensatory effect in order to protect the hepatocytes from oxidative stress. A lack of increase in lipid peroxidation by DHEA at 2 weeks when ubiquinone-10 was markedly reduced was not surprising as lipid peroxidation might be increased in specific cellular compartments and not detectable in total liver homogenates. In fact, increased lipid peroxidation in mitochondria and microsomes was observed within 3 d of feeding DHEA. 27, 28) Recent studies indicate that ubiquinone biosynthesis can be diminished in PPAR-null mice following peroxisome proliferator treatment. 29) Although DHEA is unable to transactivate the receptors, certain enzyme induction by DHEA-sulfate requires presence of the nuclear receptor. 30) Whether PPAR plays a role in enhancing DHEA mediated ubiquinone level remains to be determined.
In conclusion, the present suggests that ubiquinone-9 levels can be increased markedly upon chronic exposure to DHEA. Catalase, on the other hand, is induced for a short period. Our previous finding 31) suggests that exogenous ubiquinone significantly reduces the requirement of catalase induction in DHEA-treated rat liver. Further studies are therefore required to understand the relationship between catalase and ubiquinone following exposure to high dose DHEA.
